Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label Hemolytic Anemia. Show all posts
Showing posts with label Hemolytic Anemia. Show all posts
Thursday, March 3, 2022

FDA Approves Pyrukynd (mitapivat) as First Disease-Modifying Therapy for Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency

›
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism pioneering therapies for genetically defined diseas...
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.